SE423813B - Forfarande for framstellning av 1,5-disubstituerade pyrrolidoner med terapeutiska egenskaper - Google Patents

Forfarande for framstellning av 1,5-disubstituerade pyrrolidoner med terapeutiska egenskaper

Info

Publication number
SE423813B
SE423813B SE7708642A SE7708642A SE423813B SE 423813 B SE423813 B SE 423813B SE 7708642 A SE7708642 A SE 7708642A SE 7708642 A SE7708642 A SE 7708642A SE 423813 B SE423813 B SE 423813B
Authority
SE
Sweden
Prior art keywords
pyrrolidons
disubstituted
procedure
preparation
therapeutical properties
Prior art date
Application number
SE7708642A
Other languages
English (en)
Swedish (sv)
Other versions
SE7708642L (sv
Inventor
A J Nelson
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of SE7708642L publication Critical patent/SE7708642L/xx
Publication of SE423813B publication Critical patent/SE423813B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SE7708642A 1976-08-06 1977-07-27 Forfarande for framstellning av 1,5-disubstituerade pyrrolidoner med terapeutiska egenskaper SE423813B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US71236276A 1976-08-06 1976-08-06

Publications (2)

Publication Number Publication Date
SE7708642L SE7708642L (sv) 1978-02-07
SE423813B true SE423813B (sv) 1982-06-07

Family

ID=24861795

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7708642A SE423813B (sv) 1976-08-06 1977-07-27 Forfarande for framstellning av 1,5-disubstituerade pyrrolidoner med terapeutiska egenskaper

Country Status (31)

Country Link
JP (2) JPS5321159A (de)
AR (1) AR217080A1 (de)
AT (1) AT362887B (de)
AU (1) AU508007B2 (de)
BE (1) BE857506A (de)
BG (1) BG31073A3 (de)
CA (1) CA1077948A (de)
CH (1) CH624934A5 (de)
CS (1) CS221269B2 (de)
DD (2) DD143768A5 (de)
DE (1) DE2735904A1 (de)
DK (1) DK352077A (de)
ES (2) ES461388A1 (de)
FI (1) FI70009C (de)
FR (1) FR2369260A1 (de)
GB (2) GB1556570A (de)
GR (1) GR68688B (de)
HU (1) HU180273B (de)
IE (1) IE45505B1 (de)
IL (1) IL52615A (de)
LU (1) LU77936A1 (de)
NL (1) NL7708637A (de)
NO (1) NO772752L (de)
NZ (1) NZ184806A (de)
PH (1) PH17398A (de)
PL (2) PL112931B1 (de)
PT (1) PT66891B (de)
SE (1) SE423813B (de)
SU (3) SU703016A3 (de)
YU (1) YU192577A (de)
ZA (1) ZA774704B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5695569A (en) * 1979-12-27 1981-08-03 Canon Inc Forming method for bar lens sphere face
US4321201A (en) * 1980-09-22 1982-03-23 E. I. Du Pont De Nemours And Company Optically active tert-alkyl 7-(2-oxo-5-carbonyloxypyrrolidinyl) heptanoates
JPS59137224A (ja) * 1983-01-25 1984-08-07 Mitsubishi Electric Corp 電気鉄道用き電電圧補償装置
IL141120A0 (en) 2000-01-31 2002-02-10 Pfizer Prod Inc Use of prostaglandin (pge2) receptor 4 (epa) selective agonists for the treatment of acute and chronic renal failure
WO2002024647A1 (fr) * 2000-09-21 2002-03-28 Ono Pharmaceutical Co., Ltd. Agonistes du recepteur de l'ep4 comprenant comme principe actif des derives de la 8-azaprostaglandine
CN1476429A (zh) * 2000-11-27 2004-02-18 �Ʒ� 治疗骨质疏松的ep4受体选择性激动剂
WO2003009872A1 (en) * 2001-07-23 2003-02-06 Ono Pharmaceutical Co., Ltd. Remedies for diseases with bone mass loss having ep4 agonist as the active ingredient
DE60307607T2 (de) * 2002-03-18 2007-08-09 Pfizer Products Inc., Groton Verwendung von selektiven ep4 rezeptor agonisten zur behandlung von krankheiten
US6573294B1 (en) * 2002-05-14 2003-06-03 Allergan, Inc. 8-azaprostaglandin analogs as agents for lowering intraocular pressure
EP1586564B1 (de) * 2003-01-21 2012-11-28 Ono Pharmaceutical Co., Ltd. 8-azaprostaglandinderivate und deren medizinische verwendung

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1386146A (en) * 1972-05-03 1975-03-05 Ici Ltd Cyclopentane derivatives
JPS511460A (en) * 1974-06-24 1976-01-08 Tanabe Seiyaku Co 22 piroridonjudotaino seiho
JPS514166A (ja) * 1974-06-28 1976-01-14 Tanabe Seiyaku Co 22piroridonjudotaino seiho
US3975399A (en) * 1974-08-06 1976-08-17 E. I. Du Pont De Nemours And Company 1,5-Disubstituted-2-pyrrolidinones, -3-pyrrolin-2-ones, and -4-pyrrolin-2-ones
DE2528664A1 (de) * 1975-06-27 1977-01-13 Hoechst Ag Pyrrolidone und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
ES471349A1 (es) 1979-09-16
PL112931B1 (en) 1980-11-29
YU192577A (en) 1983-04-30
ES461388A1 (es) 1978-12-01
IL52615A (en) 1981-09-13
JPS585196B2 (ja) 1983-01-29
BE857506A (fr) 1978-02-06
GB1556569A (en) 1979-11-28
NZ184806A (en) 1980-04-28
GR68688B (de) 1982-02-01
FI70009B (fi) 1986-01-31
AT362887B (de) 1981-06-25
BG31073A3 (en) 1981-10-15
PT66891B (en) 1979-01-26
JPS5555161A (en) 1980-04-22
AU508007B2 (en) 1980-03-06
JPS5321159A (en) 1978-02-27
IL52615A0 (en) 1977-10-31
PT66891A (en) 1977-09-01
CH624934A5 (de) 1981-08-31
FI70009C (fi) 1986-09-12
HU180273B (en) 1983-02-28
FI772376A (de) 1978-02-07
AR217080A1 (es) 1980-02-29
JPS5531147B2 (de) 1980-08-15
CA1077948A (en) 1980-05-20
GB1556570A (en) 1979-11-28
PH17398A (en) 1984-08-08
AU2751577A (en) 1979-02-08
ATA579477A (de) 1980-11-15
ZA774704B (en) 1978-06-28
LU77936A1 (de) 1978-04-27
DD143768A5 (de) 1980-09-10
PL200124A1 (pl) 1978-05-22
SU850000A3 (ru) 1981-07-23
SU818480A3 (ru) 1981-03-30
NL7708637A (nl) 1978-02-08
DE2735904A1 (de) 1978-02-09
SE7708642L (sv) 1978-02-07
CS221269B2 (en) 1983-04-29
SU703016A3 (ru) 1979-12-05
DD136135A5 (de) 1979-06-20
FR2369260A1 (fr) 1978-05-26
DK352077A (da) 1978-02-07
NO772752L (no) 1978-02-07
FR2369260B1 (de) 1982-02-12
IE45505L (en) 1978-02-06
IE45505B1 (en) 1982-09-08

Similar Documents

Publication Publication Date Title
NO149389C (no) Fremgangsmaate til fremstilling av 4,1`,6`-triklor-4,1`,6`-trideoksy-galaktosukrose
SE435059B (sv) Forfarande for framstellning av med kveveheterocykliska grupper substituerade 1-fenyl-2-alkylaminoetanol-foreningar
SE441827B (sv) Forfarande for framstellning av fenoxiaminopropanoler
NO146394C (no) Analogifremgangsmaate til fremstilling av 1,2-difenyl-3-(imidazol-1-yl)-propan-2-oler med terapeutisk virkning
NO774404L (no) Fremgangsmaate for fremstilling av dimetyleter
AR224095A1 (es) Procedimiento de preparacion de nuevos derivados de ditiol-1,2 tiona-3
NO148959C (no) Fremgangsmaate ved fremstilling av tumor-motvirkende antracyklinglykosidantibiotika, betegnet ma 144
RO75777A (ro) Procedeu pentru prepararea unor 1,2-benzizotiazolin-3-one
SE441354B (sv) Forfarande for framstellning av meta-fenoxibensaldehyd
SE435387B (sv) Forfarande for framstellning av antracyklinglykosider
NO143992C (no) Fremgangsmaate for fremstilling av heksanitrostilben
SE7604475L (sv) Forfarande for framstellning av 1,1,1-triaryl-alkylaminer
NO151365C (no) Fremgangsmaate for fremstilling av 4-halogen-dihydropyran-derivater.
SE423813B (sv) Forfarande for framstellning av 1,5-disubstituerade pyrrolidoner med terapeutiska egenskaper
NO770619L (no) Fremgangsm}te for fremstilling av 2,3-substituerte-5,6-kondenserte 4(2h)-aminoalkoksy-pyranoner med hypotensiv, anti-ischaemia- og anti-hostevirkning
SE436026B (sv) Forfarande for framstellning av 13,14-dehydroprostaglandiner
RO75589A (ro) Procedeu pentru prepararea 2,6-metan-2h-1-benzoxocinei
SE434263B (sv) Forfarande for framstellning av kloretylnitrosokarbamider med antitumorverkan
NO771870L (no) Fremgangsm}te for fremstilling av 3,4-dihydro-2-metyl-4-okso-2h-1,2-benzotiazin-3-karboksylsyre-1,1-dioksyd
SE7707471L (sv) Forfarande for framstellning av 5-m-tolyloxiuracil
SE7804878L (sv) Forfarande for framstellning av 1,2-dikloretan
SE7707125L (sv) Forfarande for framstellning av 7-(alfa-(2,3, - dihydro-2-oxo-1h- bensimidazol -1- ylkarbomyl-amino) arylacetamido ) cefalasporiner
SE7712218L (sv) Forfarande for framstellning av 4a-aryloktahydro-1h-2-pyrindiner
NO771263L (no) Fremgangsm}te for fremstilling av indol-naftyridin-derivater
SE428922B (sv) Forfarande for framstellning av 13, 14-dihydro-11-dioxi-prostaglandiner